Cognition Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | -4.6% | +730.7% | -14.7% | -30.3% | -14.0% | +60.1% | |
| – | -3.5% | +754.0% | -19.2% | -28.2% | -13.6% | +62.4% | |
| – | +79.6% | +954.6% | -24.0% | -28.0% | -16.4% | +47.2% | |
| – | +79.6% | +954.6% | -24.0% | -28.0% | -16.4% | +47.2% | |
| – | -72.1% | +96.7% | +62.0% | -65.1% | +109.7% | +269.4% | |
| – | +365.0% | +266.5% | – | – | – | – | |
| – | -29.4% | -31.3% | +60.7% | – | – | – | |
| – | +14.3% | -89.6% | +29.4% | +5.0% | +7.4% | +22.9% | |
| – | -11.8% | +142.0% | -0.9% | +30.5% | +9.6% | +25.0% | |
| – | – | – | +4.0% | -8.3% | -34.3% | -6.1% | |
| – | -15.0% | +108.1% | -22.8% | +14.9% | -46.3% | -43.6% | |
| – | +86.3% | – | – | – | – | – | |
| – | – | – | -21.5% | -39.2% | -23.4% | +82.8% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +1.3% | +30.4% | +3.6% | +32.3% | +83.2% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.